American Society of Hematology

SHERPA: Blue

People

  1. Heller
    Heller
  2. O'Reilly
    O'Reilly
  3. Kernan
    Kernan
  4. Castro-Malaspina
    Castro-Malaspina
  5. Young
    Young
  6. Papadopoulos
    Papadopoulos
  7. Jakubowski
    Jakubowski
  8. Perales
    Perales
  9. Hsu
    Hsu
  10. Dupont
    Dupont

Groups

  1. Biostatistics Service (70)
  2. Epidemiology and Biostatistics (70)
  3. Department of Medicine (63)
  4. GSK Faculty (52)
  5. Center for Hematologic Malignancies (51)
  6. Hematologic Malignancies, Division of (50)
  7. Sloan Kettering Institute Faculty (50)
  8. Immunology Program Faculty (45)
  9. Tow Center for Developmental Oncology (TCDO) (40)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (39)
Search Within
  1. "Glenn Heller"
Formats
  1. Journal Article (39)
  2. Meeting Abstract (31)
Groups
  1. Biostatistics Service (70)
  2. Epidemiology and Biostatistics (70)
  3. Department of Medicine (63)
  4. GSK Faculty (52)
  5. Center for Hematologic Malignancies (51)
  6. Hematologic Malignancies, Division of (50)

More Groups

People
  1. Glenn Heller (70)
  2. Richard O'Reilly (33)
  3. Nancy Kernan (25)
  4. James Young (20)
  5. Marcel Van Den Brink (19)
  6. Hugo Castro-Malaspina (16)

More People

Years
  1. 2022 (1)
  2. 2019 (1)
  3. 2016 (1)
  4. 2014 (1)
  5. 2013 (1)
  6. 2012 (2)

More Years

Publications
  1. Blood (69)
  2. Blood Advances (1)

Results (70)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
    Journal Article

    Hasan, A. N.; Doubrovina, E.; Sottile, R.; Prockop, S.; Klatt, M. G.; Heller, G.; Selvakumar, A.; Barnett, L.; Hsu, K. C.; O’Reilly, R. J.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Selection of unrelated allogeneic hematopoietic cell donors based on KIR3DL1 allotypes is feasible and results in improved disease-free survival in transplant recipients with MDS and AML
    Meeting Abstract

    Shaffer, B. C.; Heller, G.; Le Luduec, J. B.; Vahradian, J.; Perales, M.; Giralt, S. A.; Tamari, R.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
    Journal Article

    Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1
    Journal Article

    Romano, E.; Cotari, J. W.; da Silva, R. B.; Betts, B. C.; Chung, D. J.; Avogadri, F.; Fink, M. J.; St Angelo, E. T.; Mehrara, B.; Heller, G.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV(+) lymphomas after allogeneic hematopoietic cell transplantation
    Journal Article

    Doubrovina, E.; Oflaz-Sozmen, B.; Prockop, S. E.; Kernan, N. A.; Abramson, S.; Teruya-Feldstein, J.; Hedvat, C.; Chou, J. F.; Heller, G.; Barker, J. N.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic hematopoietic stem cell transplantation with busulfan, melphalan, and fludarabine conditioning followed by post transplantation donor lymphocyte infusions for patients with relapsed multiple myeloma and high-risk cytogenetics
    Meeting Abstract

    Koehne, G.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Rosenzweig, M. A.; Heller, G.; Giralt, S.
    Blood (2011)

    Fulltext@MSK | Save
  • Janus kinase-2 inhibition induces durable tolerance to alloantigen by dendritic cell-stimulated human T cells, yet preserves immunity to recall antigen
    Meeting Abstract

    Betts, B. C.; Abdel-Wahab, O.; Curran, S. A.; St Angelo, E. T.; Koppikar, P.; Heller, G.; Levine, R. L.; Young, J. W.
    Blood (2011)

    Fulltext@MSK | Save
  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Journal Article

    Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
    Blood (2011)

    Fulltext@MSK | Save